Simultaneous determination of reserpine, rescinnamine, and yohimbine in human plasma by ultraperformance liquid chromatography tandem mass spectrometry

  • Muzaffar Iqbal
  • , Aftab Alam
  • , Tanveer A. Wani
  • , Nasr Y. Khalil

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

A sensitive and selective UPLC-MS/MS method was developed and validated for the determination of three indolic alkaloids (reserpine, rescinnamine, and yohimbine) in human plasma using papaverine as internal standard (IS). After a one step protein precipitation with acetonitrile, separation was carried out using C18 column (50 × 2.1 mm, i.d. 1.7 m) and mobile phase consisting of acetonitrile: water: formic acid (60: 40: 0.1%, v/v/v) pumped at a flow rate of 0.2 mL/min. The mass spectrometric determination was carried out using an electrospray interface operated in the positive mode with multiple reaction monitoring (MRM) mode. The precursor to product ion transitions of m/z 609.32 > 195.01, m/z 635.34 > 221.03, m/z 355.19 > 144, and m/z 340.15 > 202.02 were selected for the quantification of reserpine, rescinnamine, yohimbine, and IS, respectively. The analytical response was found to be linear in the range of 0.36-400, 0.27-300, and 0.23-250 ng/mL with lower limit of quantification of 0.36, 0.27, and 0.23 ng/mL for reserpine, rescinnamine, and yohimbine, respectively. Validation was made following official guidelines. The proposed method enabled reproducible results and hence could be reliable for pharmacokinetic and toxicological analysis.

Original languageEnglish
Article number940861
JournalJournal of Analytical Methods in Chemistry
Volume2013
DOIs
StatePublished - 2013
Externally publishedYes

Fingerprint

Dive into the research topics of 'Simultaneous determination of reserpine, rescinnamine, and yohimbine in human plasma by ultraperformance liquid chromatography tandem mass spectrometry'. Together they form a unique fingerprint.

Cite this